Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« A Personal Perspective on Neurotechnology | Main | Pharma's Industrial Implosion »

April 24, 2003

Live Better with Many-to-Many

Email This Entry

Posted by Zack Lynch

Humans are social creatures.  If you feed a newborn but don't provide it social interaction it will grow up with severe mental illnesses.  This conclusion was determined by studying monkeys, not humans. 


Social interaction is the hallmark of the human species.  On this note, the emergence of social software will inevitably foster, in its own way, more effective human interaction on a global scale. 


To keep you abreast of the latest developments in social software, Corante has launched a new blog today, many-to-many which will have contributions from leading thinkers across the social software space.

Comments (0) | Category: Writing & Blogging



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives